Article by Joanna Lewis, PharmD, MBA, Pharmacy Times
“Diabetes affects about 30.3 million individuals in the United States, according to the CDC’s most recent estimate. In addition, the CDC estimates that among people aged 18 and older, about 84.1 million have prediabetes, a condition characterized by blood sugar levels higher than normal but not high enough for a diabetes diagnosis (eg, fasting plasma glucose, 100-125 mg/dL; glycated hemoglobin [A1C], 5.7%-6.4%).1,2 Individuals with prediabetes are also more prone to heart disease, stroke, and type 2 diabetes (T2D).
Diabetes, a group of diseases characterized by high blood sugar, is the seventh-leading cause of death in the United States, and complications from uncontrolled diabetes can also cause gum and kidney disease, vision loss, and peripheral diabetic neuropathy, potentially resulting in foot problems. Comorbid conditions, such as heart disease and stroke, are also more common in people with diabetes.
The American Diabetes Association (ADA) recommends a team-based approach to managing a patient’s diabetes.3 Findings from many studies back up the contributions that clinical pharmacists make as part of the interdisciplinary team treating patients with diabetes.”